Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine

References

• Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981; 1: 681–686
   PubMed Web of Science ®Google Scholar
• Arkovitz MS, Szabo C, Garcia VF, Wong HR, Wispe JR. Differential effects of hyperoxia on the inducible and constitutive isoforms of nitric oxide synthase in the lung. Shock 1997; 7: 345–350
   PubMed Web of Science ®Google Scholar
• Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593–597
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269–280
   PubMed Web of Science ®Google Scholar
• Bearden SE, Cheuvront SN, Ring TA, Haymes EM. Oxidative stress during a 3.5-hour exposure to 120 kPa(a) PO2 in human divers. Undersea Hyperb Med 1999; 26: 159–164
   PubMed Web of Science ®Google Scholar
• Burgunder JM, Varriale A, Lauterburg BH. Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol 1989; 36: 127–131
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004; 59: 1016–1019
   PubMed Web of Science ®Google Scholar
• Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, Moutinho dos SJ. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999; 14: 1002–1008
   PubMed Web of Science ®Google Scholar
• Crockett AJ, Cranston JM, Moss JR, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2000, CD001744
   Google Scholar
• Fariss MW, Reed DJ. High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives. Methods Enzymol 1987; 143: 101–109
   PubMed Web of Science ®Google Scholar
• Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256: 10986–10992
   PubMed Web of Science ®Google Scholar
• Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997; 52: 674–679
   PubMed Web of Science ®Google Scholar
• Grattagliano I, Vendemiale G, Sabba C, Buonamico P, Altomare E. Oxidation of circulating proteins in alcoholics: Role of acetaldehyde and xanthine oxidase. J Hepatol 1996; 25: 28–36
   PubMed Web of Science ®Google Scholar
• Holdiness MR. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 1991; 20: 123–134
   PubMed Web of Science ®Google Scholar
• Levine RL, Wehr N, Williams JA, Stadtman ER, Shacter E. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 2000; 99: 15–24
   PubMedGoogle Scholar
• Li XY, Donaldson K, Rahman I, MacNee W. An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am J Respir Crit Care Med 1994; 149: 1518–1525
   PubMed Web of Science ®Google Scholar
• MacNee W. Oxidants/antioxidants and COPD. Chest 2000; 117: 303S–317S
   PubMed Web of Science ®Google Scholar
• Mantell LL, Lee PJ. Signal transduction pathways in hyperoxiainduced lung cell death. Mol Genet Metab 2000; 71: 359–370
   PubMed Web of Science ®Google Scholar
• Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 1991; 51: 155–194
   PubMed Web of Science ®Google Scholar
• Menzel DB. Antioxidant vitamins and prevention of lung disease. Ann NY Acad Sci 1992; 669: 141–155
   PubMed Web of Science ®Google Scholar
• Morcillo EJ, Estrela J, Cortijo J. Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants. Pharmacol Res 1999; 40: 393–404
   PubMed Web of Science ®Google Scholar
• O'Donohue WJ, Jr, Plummer AL. Magnitude of usage and cost of home oxygen therapy in the United States. Chest 1995; 107: 301–302
   PubMed Web of Science ®Google Scholar
• Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 1988; 34: 77–82
   PubMed Web of Science ®Google Scholar
• Paredi P, Kharitonov SA, Barnes PJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med 2002; 166: S31–S37
   Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256–1276
   PubMedGoogle Scholar
• Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977; 83: 346–356
   PubMed Web of Science ®Google Scholar
• Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996; 51: 348–350
   PubMed Web of Science ®Google Scholar
• Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055–1060
   PubMed Web of Science ®Google Scholar
• Rahman I, Swarska E, Henry M, Stolk J, MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?. Thorax 2000; 55: 189–193
   PubMed Web of Science ®Google Scholar
• Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997; 156: 341–357
   PubMed Web of Science ®Google Scholar
• Santini MT, Straface E, Cipri A, Peverini M, Santulli M, Malorni W. Structural alterations in erythrocytes from patients with chronic obstructive pulmonary disease. Haemostasis 1997; 27: 201–210
   PubMedGoogle Scholar
• Straface E, Matarrese P, Gambardella L, Forte S, Carlone S, Libianchi E, Schmid G, Malorni W. N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2000; 279: 552–556
   PubMed Web of Science ®Google Scholar
• Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med 1995; 333: 710–714
   PubMed Web of Science ®Google Scholar
• Vacchiano CA, Osborne GR, Tempel GE. 8-ISO-PGF2alpha production by alveolar macrophages exposed to hyperoxia. Shock 1998; 9: 266–273
   PubMed Web of Science ®Google Scholar
• Vina J, Servera E, Asensi M, Sastre J, Pallardo FV, Ferrero JA, Garcia-De-La-Asuncion J, Anton V, Marin J. Exercise causes blood glutathione oxidation in chronic obstructive pulmonary disease: prevention by O2 therapy. J Appl Physiol 1996; 81: 2198–2202
   PubMed Web of Science ®Google Scholar